TSMM 1120

In November’s issue of The Small Molecule Manufacturer, industry experts discuss best practices for handling HPAPIs in our cover feature. We also explore how 3D printing can be used to improve therapeutic options for the blind and visually impaired in the Next Big Thing, as well as how drug developers can best handle solubility-challenged molecules. And we sit down with Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia, who explains how the COVID-19 pandemic has affected her first year at the company.

Register to download

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Manufacture COVID-19

Fancy a Game of Ping-Pong?

11/05/2020 | Stephanie Vine

When following COVID-19 research, it’s hard to keep your eye on the ball...

Discovery & Development Drug Discovery

The Gut Response

10/27/2020 | Maryam Mahdi

In what ways can the microbiome interact with oral medicines?

Discovery & Development Clinical Trials

Pandemic Protection

10/29/2020 | Stephanie Vine

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Manufacture Small Molecules

Think Small

11/06/2020 | Stephanie Vine

Researchers create micro-feeder that eases the handling of small quantities of powder.

Business & Regulation Standards & Regulation

Virtual Support

12/12/2020 | Maryam Mahdi

How the EMA plans to help researchers and developers make better medicines.

Manufacture Technology and Equipment

A Tactile Experience

11/07/2020 | Maryam Mahdi

How can we improve medicines for the blind and visually impaired?

Discovery & Development Contract Manufacturing Services

Getting a Handle on High Potency

11/03/2020 | Maryam Mahdi

How can companies avoid the risks of HPAPI containment and handling?

Manufacture Small Molecules

From Brick Dust to Blockbuster

11/04/2020 | David K. Lyon

How can we best deliver solubility-challenged small molecules to the clinic?

Business & Regulation Business Practice

Adapting to Change

10/30/2020 | Maryam Mahdi

Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.

Other issues of 2020